Hanmi Science Co., Ltd.

₩54,300As of Sun 8 Nov 2026, 12:00 UTC
KRX:008930Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (1.06%)
Div yield 0.55%
ROE 15.54%
Medical Distribution
Beta (5Y) 0.48
PE TTM 24.38
TSR TTM 38.90%
Mkt cap ₩3.679T
ROIC 5.16%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩67,757
24.78%
(96.88%)
Hold 8|10|2|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
1,245
1,212
1,323
1,476
33.95%
21.79%
18.88%
21.92%
Revenue₩B
189.1
196.0
191.1
186.6
(5.06%)
1.12%
(0.60%)
(3.47%)
Peers (US$2.712B)
Cap (US$)
PE
3.063B
—
2.568B
10.64x
Capital
TTM
5Y
10Y
Leveragex
2.487
0.196
0.165
EBIT/Intx
0.788
1.371
1.020
Own earn%
98.61
(68.06)
(64.93)
Sh yield%
43.91
23.85
21.47
Owners
Insiders/Inst%
10.03
33.38
Short interest%
3.08
SBC / revenue%
2.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
4–7
$1 testx
0.2
Incr. ROIC%
10